Natalia Wilson
Biographic Data
| ID | 8306554 |
|---|---|
| NAME | Natalia Wilson |
| GIVEN NAMES | Natalia |
| FAMILY NAME | Wilson |
| SIGNATURE | WILSON N |
| AFFILIATIONS | Center for Excellence in Education |
| ORCID | 0000-0002-6531-7776 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Patient perspectives on the need for implanted device information
BACKGROUND: Shared decision making and patient-centred communication have become part of pre-procedural decisions and perioperative care across medical specialties. However, gaps exist in patient communication about the implanted device received and the benefits in sharing information about their procedure and device. OBJECTIVE: To understand the patients' knowledge of identifying information for their implanted devices and perspectives on sharin…
FDA Device Oversight From 1906 to the Present
This article examines the history of device oversight by the US Food and Drug Administration (FDA). Significant regulatory changes occurred in response to injuries caused by Dalkon Shield intrauterine devices. This article summarizes those changes as well as continued efforts by the FDA to strengthen device oversight and address areas of concern
No prominent works on this page.
Patient perspectives on the need for implanted device information
BACKGROUND: Shared decision making and patient-centred communication have become part of pre-procedural decisions and perioperative care across medical specialties. However, gaps exist in patient communication about the implanted device received and the benefits in sharing information about their procedure and device. OBJECTIVE: To understand the patients' knowledge of identifying information for their implanted devices and perspectives on sharin…
FDA Device Oversight From 1906 to the Present
This article examines the history of device oversight by the US Food and Drug Administration (FDA). Significant regulatory changes occurred in response to injuries caused by Dalkon Shield intrauterine devices. This article summarizes those changes as well as continued efforts by the FDA to strengthen device oversight and address areas of concern
Administration (probate law (1 work) · Biomedical Ethics and Regulation (1 work) · Business (1 work) · Cardiac pacing and defibrillation studies (1 work) · Computer Science (1 work) · Electronic Health Records Systems (1 work) · Food and drug administration (1 work) · Knowledge management (1 work) · Law (1 work) · Law (1 work)